Miriam Kidron Ph.D.
Net Worth

Last updated:

What is Miriam Kidron Ph.D. net worth?

The estimated net worth of Dr. Miriam Kidron Ph.D. is at least $5,237,092 as of 14 Mar 2023. He owns shares worth $415,432 as insider, has earned $201,000 from insider trading and has received compensation worth at least $4,620,660 in Oramed Pharmaceuticals Inc..

What is the salary of Miriam Kidron Ph.D.?

Dr. Miriam Kidron Ph.D. salary is $420,060 per year as Chief Scientific Officer & Director in Oramed Pharmaceuticals Inc..

How old is Miriam Kidron Ph.D.?

Dr. Miriam Kidron Ph.D. is 85 years old, born in 1940.

What stocks does Miriam Kidron Ph.D. currently own?

As insider, Dr. Miriam Kidron Ph.D. owns shares in one company:

Company Title Shares Price per share Total value
Oramed Pharmaceuticals Inc. (ORMP) Chief Scientific Officer & Director 201,666 $2.06 $415,432

What does Oramed Pharmaceuticals Inc. do?

Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or pills for delivery of polypeptides. Its proprietary flagship product is the ORMD-0801, an orally ingestible insulin capsule, which completed phase II clinical trials for the treatment of individuals with diabetes. It is also developing ORMD-0901, an oral glucagon-like peptide-1 capsule that has completed phase I clinical trials for the treatment of type 2 diabetes; and a weight loss treatment in the form of an oral leptin capsule. The company was formerly known as Integrated Security Technologies, Inc. and changed its name to Oramed Pharmaceuticals Inc. in April 2006. Oramed Pharmaceuticals Inc. was founded in 2002 and is based in New York, New York.

ORMP logo
ORMP
Oramed Pharmaceuticals Inc.
$2.06

Miriam Kidron Ph.D. insider trading

Oramed Pharmaceuticals Inc.

Dr. Miriam Kidron Ph.D. has made 10 insider trades between 2014-2023, according to the Form 4 filled with the SEC. Most recently he sold 100,000 units of ORMP stock worth $201,000 on 14 Mar 2023.

The largest trade he's ever made was exercising 142,814 units of ORMP stock on 1 Aug 2014. As of 14 Mar 2023 he still owns at least 201,666 units of ORMP stock.

Transaction Date Security Shares Price per share Total value Source
Sale
Common Stock 100,000 $2.01 $201,000
Sale
Common Stock 89,636 N/A N/A
Sale
Common Stock 52,814 N/A N/A
Sale
Common Stock 24,000 N/A N/A
Sale
Common Stock 15,000 N/A N/A
Sale
Common Stock 11,000 N/A N/A
Sale
Common Stock 8,699 N/A N/A
Sale
Common Stock 23,000 N/A N/A
Sale
Common Stock 8,301 N/A N/A
Option
Common Stock 142,814 N/A N/A
Option
Warrant (right to buy) 142,814 N/A N/A
Sale
Common Stock 137,300 N/A N/A
Option
Warrant (right to buy) 137,300 N/A N/A
Option
Common Stock 137,300 N/A N/A

Oramed Pharmaceuticals key executives

Oramed Pharmaceuticals Inc. executives and other stock owners filed with the SEC: